We are live on ! Find out more
TAM

Tocqueville Asset Management Portfolio holdings

AUM $7.56B
1-Year Est. Return 44.87%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+44.87%
3 Year Est. Return
+121.98%
5 Year Est. Return
+153.06%
10 Year Est. Return
+501.33%
AUM
$5.23B
AUM Growth
+$432M
Cap. Flow
-$77.4M
Cap. Flow %
-1.48%
Top 10 Hldgs %
25.64%
Holding
696
New
43
Increased
170
Reduced
285
Closed
48

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$22.8M
2
SCHW
Charles Schwab
SCHW
+$18.4M
3
ELAN icon
Elanco Animal Health
ELAN
+$14.8M
4
NEM icon
Newmont
NEM
+$13.1M
5
BXP icon
Boston Properties
BXP
+$11.9M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.9M
2
NVDA icon
NVIDIA
NVDA
+$9.88M
3
LVS icon
Las Vegas Sands
LVS
+$9.7M
4
BNY
Bank of New York Mellon
BNY
+$9.63M
5
CSCO icon
Cisco
CSCO
+$8.91M

Sector Composition

Rank Sector Weight
1 Technology 18.61%
2 Consumer Discretionary 17.32%
3 Healthcare 12.32%
4 Miscellaneous 11.15%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVA icon
576
Innoviva
INVA
$1.51B
$116K ﹤0.01%
+11,084
New +$141K
AMRN
577
Amarin Corp
AMRN
$298M
$79K ﹤0.01%
943
-162
-15% -$19.4K
BMY.RT
578
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$49K ﹤0.01%
21,743
-1,800
-8% -$5.14K
SEEL
579
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$37K ﹤0.01%
10
-37
-79% -$133K
AUD
580
DELISTED
Audacy, Inc.
AUD
$20K ﹤0.01%
12,370
– –
ACAD icon
581
Acadia Pharmaceuticals
ACAD
$5.12B
– –
-13,625
Closed -$660K
AMN icon
582
AMN Healthcare
AMN
$1.35B
– –
-75,341
Closed -$3.41M
AXTI icon
583
AXT Inc
AXTI
$4.41B
– –
-20,950
Closed -$100K
AXSM icon
584
Axsome Therapeutics
AXSM
$10.8B
– –
-2,500
Closed -$206K
BCE icon
585
BCE
BCE
$21.8B
– –
-15,200
Closed -$635K
CAH icon
586
Cardinal Health
CAH
$54.7B
– –
-5,381
Closed -$281K
VISN
587
Vistance Networks Inc
VISN
$2.66B
– –
-16,400
Closed -$137K
COR icon
588
Cencora
COR
$61.4B
– –
-2,943
Closed -$297K
CRI icon
589
Carter's
CRI
$1.22B
– –
-5,200
Closed -$420K
E icon
590
ENI
E
$76.7B
– –
-15,000
Closed -$289K
EEFT icon
591
Euronet Worldwide
EEFT
$2.58B
– –
-2,500
Closed -$240K
EL icon
592
Estee Lauder
EL
$38.3B
– –
-4,584
Closed -$865K
ESPR
593
DELISTED
Esperion Therapeutics
ESPR
– –
-5,500
Closed -$282K
GEN icon
594
Gen Digital
GEN
$18.1B
– –
-30,204
Closed -$599K
GTX icon
595
Garrett Motion
GTX
$5.11B
– –
-179,378
Closed -$994K
IEF icon
596
iShares 7-10 Year Treasury Bond ETF
IEF
$43B
– –
-100,000
Closed -$630K
INO icon
597
Inovio Pharmaceuticals
INO
$130M
– –
-667
Closed -$216K
ITUB icon
598
Itaú Unibanco
ITUB
$83B
– –
-218,518
Closed -$746K
LAMR icon
599
Lamar Advertising Co
LAMR
$15.2B
– –
-4,655
Closed -$311K
LDOS icon
600
Leidos
LDOS
$17.5B
– –
-3,715
Closed -$348K
21 22 23
24
25

Similar funds

RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
CCWA
CLA (CliftonLarsonAllen) Wealth Advisors Minneapolis, Minnesota $7.61B AUM 16.44% 1-Year Est. Return

Tocqueville Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Tocqueville Asset Management held 696 positions worth $5.23B, up 9% from $4.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Tocqueville Asset Management's Q3 2020 filing shows 43 new, 170 increased, 285 reduced and 48 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 225,520 shares worth $17.2M. The largest sale was Apple, an estimated $12.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Tocqueville Asset Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 225,520 shares worth $17.2M.
  • Tocqueville Asset Management added most to Charles Schwab in Q3 2020, an estimated $18.4M increase.
  • Tocqueville Asset Management's biggest Q3 2020 reduction was Apple, cutting an estimated $12.9M.
  • Tocqueville Asset Management fully exited Las Vegas Sands in Q3 2020, selling an estimated $9.7M.
  • Tocqueville Asset Management's ten largest holdings make up 26% of its $5.23B portfolio in Q3 2020.
  • Tocqueville Asset Management opened 43 new positions and closed 48 in Q3 2020.
  • Tocqueville Asset Management's portfolio value rose 9% quarter-over-quarter to $5.23B.

Based on Tocqueville Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.